Phase I trial of NKTR 171 for the treatment of neuropathic pain.

Trial Profile

Phase I trial of NKTR 171 for the treatment of neuropathic pain.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Feb 2015

At a glance

  • Drugs NKTR-171 (Primary)
  • Indications Neuropathic pain
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Nektar Therapeutics
  • Most Recent Events

    • 26 Feb 2015 Status changed from recruiting to completed as per SEC filing of Nektar Therapeutics (http://ir.nektar.com/secfiling.cfm?filingID=1193125-15-63338).
    • 14 Jan 2014 Status changed from planning to recruiting, as reported in a Nektar Therapeutics media release (the first subjects have been dosed).
    • 25 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top